Literature DB >> 33398389

[Psychiatric comorbidities in hidradenitis suppurativa/acne inversa].

Paraskevi Mavrogiorgou1, Georg Juckel2, Andreas Reimelt1, Schapoor Hessam3,4, Lisa Scholl3, Jessica Lisa Frajkur1, Eggert Stockfleth3, Falk G Bechara3.   

Abstract

BACKGROUND: The findings of most studies suggest that depression and anxiety disorders are the most common psychiatric comorbidities in patients with hidradenitis suppurativa/acne inversa (HS/AI).
METHODS: In a prospective study, 51 patients with HS/AI were further examined for psychiatric comorbidity using a standardized interview and questionnaires.
RESULTS: In psychiatric examination, 29.4% of HS/AI patients had additional mental symptoms, mainly manifested as depressive disorder. The HS/AI patients were rather young and female, and they showed a high incidence of nicotine and alcohol use, and a positive family history of paternal alcohol dependence. In addition, HS/AI patients experienced more severe psychosocial impairments in the form of lack of partnership and lower school attainment.
CONCLUSIONS: Acne inversa is a severe chronic inflammatory skin disease that, like other inflammatory dermatoses, is associated with mental comorbidity and psychosocial impairments. Since especially young patients are affected, a psychiatric-psychotherapeutic cotreatment should be considered already at an early stage.

Entities:  

Keywords:  Anxiety disorders; Chronic inflammatory diseases of the skin; Depression; Mental disorders; Psychosocial impairment

Mesh:

Year:  2021        PMID: 33398389     DOI: 10.1007/s00105-020-04742-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  38 in total

Review 1.  Inflammation: A Contributor to Depressive Comorbidity in Inflammatory Skin Disease.

Authors:  Delaram Farzanfar; Yekta Dowlati; Lars E French; Michelle A Lowes; Afsaneh Alavi
Journal:  Skin Pharmacol Physiol       Date:  2018-06-28       Impact factor: 3.479

2.  Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement.

Authors:  Inge E Deckers; Hessel H van der Zee; Jurr Boer; Errol P Prens
Journal:  J Am Acad Dermatol       Date:  2015-01-10       Impact factor: 11.527

3.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

4.  Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study.

Authors:  Florence Canoui-Poitrine; Aurélie Le Thuaut; Jean E Revuz; Cédric Viallette; Germaine Gabison; Florence Poli; Florence Pouget; Pierre Wolkenstein; Sylvie Bastuji-Garin
Journal:  J Invest Dermatol       Date:  2012-12-13       Impact factor: 8.551

5.  Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: A population-based analysis in the United States.

Authors:  Amit Garg; Vassiliki Papagermanos; Margaretta Midura; Andrew Strunk; Jonathan Merson
Journal:  J Am Acad Dermatol       Date:  2018-03-01       Impact factor: 11.527

6.  Risk of developing major depressive disorder and anxiety disorders among adolescents and adults with atopic dermatitis: a nationwide longitudinal study.

Authors:  Chih-Ming Cheng; Ju-Wei Hsu; Kai-Lin Huang; Ya-Mei Bai; Tung-Ping Su; Cheng-Ta Li; Albert C Yang; Wen-Han Chang; Tzeng-Ji Chen; Shih-Jen Tsai; Mu-Hong Chen
Journal:  J Affect Disord       Date:  2015-03-05       Impact factor: 4.839

7.  Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity.

Authors:  Florence Canoui-Poitrine; Jean E Revuz; Pierre Wolkenstein; Cédric Viallette; Germaine Gabison; Florence Pouget; Florence Poli; Ousmane Faye; Sylvie Bastuji-Garin
Journal:  J Am Acad Dermatol       Date:  2009-04-29       Impact factor: 11.527

8.  Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States.

Authors:  Irene Cosmatos; Amy Matcho; Rachel Weinstein; Michael O Montgomery; Paul Stang
Journal:  J Am Acad Dermatol       Date:  2012-08-24       Impact factor: 11.527

Review 9.  Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management.

Authors:  Madhulika A Gupta; Aditya K Gupta
Journal:  Am J Clin Dermatol       Date:  2003       Impact factor: 7.403

10.  Reduced ten-eleven translocation and isocitrate dehydrogenase expression in inflammatory hidradenitis suppurativa lesions.

Authors:  Schapoor Hessam; Thilo Gambichler; Marina Skrygan; Michael Sand; Ines Rüddel; Lisa Scholl; Falk G Bechara
Journal:  Eur J Dermatol       Date:  2018-08-01       Impact factor: 2.805

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.